CLINICAL_TRIALS
trial_result
· 2022-05-04
Clinical Trial Update: A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia [Phase 2]
Summary
Phase 2 study completed evaluating RDX013 for hyperkalemia, assessing safety and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardelyx | Conditions: Hyperkalemia | Phase 2 | Status: COMPLETED